Precision glycoengineered AAV capsids enhance hepatocyte targeting and attenuated immune activation for liver-directed gene therapy
Authors:
- 11 June 2026
- journal article
- Published by Elsevier in Biomaterials
- Vol. 335, 124381
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (91753202)
- National Natural Science Foundation of China (82130100)
- National Natural Science Foundation of China (32370156)
- National Natural Science Foundation of China (82173724)
- National Key Research and Development Program of China (2024YFA0917500)
This publication has 106 references indexed in Scilit:
- A Shape‐Recovery Polycationic Fibroin for Hemostasis‐Regeneration Transition by Recapitulating Natural Coagulation NetworksAdvanced Materials, 2025
- Sialyl Lewis X decorated integrin α3 on small extracellular vesicles promotes metastasis of bladder cancer via enhancing vascular permeabilityAngiogenesis, 2024
- Site-specific tethering nanobodies on recombinant adeno-associated virus vectors for retargeted gene therapyActa Biomaterialia, 2024
- Surface Plasmon Resonance: A Sensitive Tool to Study Protein–Protein Interactions2023
- Pharmacokinetics and Pharmacodynamics of GalNAc‐Conjugated siRNAsThe Journal of Clinical Pharmacology, 2023
- Adeno‐associated virus serotype 2 capsid variants for improved liver‐directed gene therapyHepatology, 2023
- Clinical Study of Single‐Stranded Oligonucleotide RO7062931 in Healthy Volunteers and Patients With Chronic Hepatitis BHepatology, 2021
- Precision Fluorescent Labeling of an Adeno‐Associated Virus Vector to Monitor the Viral Infection PathwayBiotechnology Journal, 2018
- Efficient production of Fah -null heterozygote pigs by chimeric adeno-associated virus-mediated gene knockout and somatic cell nuclear transferHepatology, 2011
- Route of Administration Determines Induction of T-Cell-Independent Humoral Responses to Adeno-Associated Virus VectorsMolecular Therapy, 2000